Kyowa Kirin Australia Pty Ltd(オーストラリア) 別ウィンドウで開く
基本情報
- 所在地
- シドニーCBD
- 社長
- 従業員数(単独)
- 従業員数(連結)
- 開始日
- 2019-01-01
- 終了日
サイト
事業内容
関連会社
| 会社名 | Group | 親会社 | 子会社 | 得意先 | 仕入先 | 業務提携 | 銀行等 | 株主等 |
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
| Kyowa Kirin Group | ||||||||
|
|
||||||||
| BioWa, Inc. | ||||||||
| Kyowa Kirin USA Holdings, Inc. | ||||||||
| CRT Japan | ||||||||
| Caux Round Table Japan (CRT Japan) | ||||||||
| Japan Center for Engagement and Remedy on Business and Human Rights (JaCER) | ||||||||
| Pharmaceutical Supply Chain Initiative (PSCI) |
関連図
沿革
Agreement reached with Amgen to jointly develop and commercialize KHK4083, a Kyowa Kirin-discovered anti-OX40 fully human monoclonal antibody.![]()
Declared support for the recommendations of the Task Force on Climate-Related Financial Disclosures (TCFD).![]()
An automated injection device "G-Lasta® Subcutaneous Injection 3.6 mg BodyPod" launched in Japan for the long-acting G-CSF preparation, G-Lasta®.![]()
Q-TOWER, the new biopharmaceutical analysis facility completed at Takasaki Plant, Kyowa Kirin's major biopharmaceutical manufacturing site.![]()
PHOZEVEL® approved in Japan for the treatment of Hyperphosphatemia in chronic kidney disease patients.![]()
Kyowa Kirin announced the acquisition of UK company Orchard Therapeutics with strength in hematopoietic stem cell gene therapy.![]()
ニュース
ニュースはありません。